Spastic Diplegia
Conditions
Brief summary
PURPOSE: The purpose of this study will be investigation of the effect oflight stimulated footsteps pathway on kinematics of gait in spastic diplegic children BACKGROUND: The goal of most therapy procedures for children with spastic cerebral palsy is to increase their walking abilities. Locomotor training usinglight stimulated footsteps pathwayhas been recommended for the rehabilitation of children with cerebral palsy in an effort to improve walking independence and gait speed. HYPOTHESES: Walking on light stimulated footsteps pathway may not affect kinematics of gait in spastic diplegic children RESEARCH QUESTION: Does walking on light stimulated footsteps pathway have any effect onkinematics of gait in spastic diplegic children?
Interventions
OTHERtherapeutic exercise
Balance training from different positions. Weight shifting exercises by facilitation of single limb support while standing. Ascending and descending stairs. Gait training between parallel bars applied three times per week for three month
OTHERgait training on light stimulated footsteps pathway
same routine program as the control group as well as 30 minutes of gait training on light stimulated footsteps pathway: 1. Walk on the light stimulated footsteps (Forward steps) 2. Walk on the light stimulated footsteps (backward steps) 3. Tandem gait over light yellow line applied three times per week for three month
Sponsors
Amira saad mohamed
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
4 Years to 8 Years
Healthy volunteers
No
Inclusion criteria
* Age will range between5 and 8 years old. * They had Grade 1 and 1+ hypertonia according to Modified Ashworth Scale (Bohannon and Smith, 1987) * Motor Classification System, they were at level I and II (GMFCS) * They will capable of following commands and comprehend them. * They will exhibit defective gait kinematics, which can be determined through gait kinematics evaluation. * All patients who will be enrolled to the study will have their informed consent.
Exclusion criteria
* Epilepsy history. * Taking any anti spastic drugs. * Both lower limbs had permanent deformity. * Surgical intervention history. * Have visual or auditory defects. * Chest infections or unstable cardiac status. * Infective skin conditions. * Markedly high or low blood pressure. * Individuals with cardiopulmonary conditions. * Individuals with any pelvic disease. * Individuals undergoing radiation therapy or chemotherapy. * Hepatic or pancreatic diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| step length | At baseline and re assessed following 3 months | kinovea software used to evaluate step length The unit of measurement for Step Length is centimeter (cm) |
| step width | At baseline and re assessed following 3 months | kinovea software used to evaluate step width The unit of measurement for Step width is centimeter (cm) |
| spasticity | At baseline and re assessed following 3 months | The Modified Ashworth Scale (MAS) used for evaluation MAS assigns a grade of spasticity from a 0-4 ordinal scale. The grade is assigned by moving a joint/muscle through a high velocity quick stretch. |
| gross motor function | At baseline and re assessed following 3 months | The Gross Motor Function Measure (GMFM) is a standardized tool used to assess changes in gross motor function in children, particularly those with cerebral palsy. The GMFM uses a four-point ordinal scale for scoring each item, where: 0: Does not initiate 1. Initiates (but does not complete) 2. Partially completes 3. Completes the task fully Scores can be summed to calculate raw and percent scores for each dimension and a total GMFM score. |
Countries
Egypt
Outcome results
None listed